MARASCIO, Nadia
 Distribuzione geografica
Continente #
NA - Nord America 2.940
AS - Asia 1.933
EU - Europa 1.154
SA - Sud America 378
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 38
OC - Oceania 2
Totale 6.643
Nazione #
US - Stati Uniti d'America 2.850
SG - Singapore 904
IT - Italia 616
CN - Cina 420
BR - Brasile 280
VN - Vietnam 197
IN - India 186
DE - Germania 145
GB - Regno Unito 79
SE - Svezia 70
FI - Finlandia 67
HK - Hong Kong 55
CA - Canada 53
AR - Argentina 41
NL - Olanda 34
MX - Messico 26
CZ - Repubblica Ceca 22
BD - Bangladesh 21
FR - Francia 21
TR - Turchia 19
ES - Italia 16
IQ - Iraq 15
JP - Giappone 14
PL - Polonia 14
VE - Venezuela 14
PK - Pakistan 13
ID - Indonesia 12
ZA - Sudafrica 12
UZ - Uzbekistan 11
CL - Cile 9
EC - Ecuador 9
RO - Romania 9
RU - Federazione Russa 8
AT - Austria 7
IR - Iran 7
MT - Malta 7
PE - Perù 7
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
IL - Israele 5
LT - Lituania 5
PH - Filippine 5
SA - Arabia Saudita 5
UA - Ucraina 5
UY - Uruguay 5
AZ - Azerbaigian 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
HR - Croazia 3
IE - Irlanda 3
LV - Lettonia 3
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
PT - Portogallo 2
SC - Seychelles 2
TN - Tunisia 2
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BS - Bahamas 1
EU - Europa 1
GD - Grenada 1
KH - Cambogia 1
KI - Kiribati 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 6.446
Città #
San Jose 675
Singapore 347
Ashburn 336
Dallas 195
Chandler 180
Santa Clara 157
Bengaluru 138
Hefei 138
Council Bluffs 125
Milan 114
Munich 105
Lawrence 92
Princeton 92
Beijing 74
Chicago 61
Ho Chi Minh City 59
Wilmington 55
London 53
Rome 51
Hanoi 50
Hong Kong 50
Turku 50
Los Angeles 41
Boardman 40
São Paulo 31
Ottawa 27
New York 26
Palermo 23
Des Moines 22
Olomouc 21
Crotone 20
Catanzaro 19
Florence 18
San Francisco 18
Naples 17
Brooklyn 16
Helsinki 16
Chennai 14
Norwalk 13
Tokyo 13
Haiphong 11
Da Nang 10
Mexico City 10
San Nicola Manfredi 10
Warsaw 10
Orem 9
Padova 9
Tashkent 9
Baghdad 8
Boston 8
Buffalo 8
Montreal 8
Shanghai 8
Atlanta 7
Brasília 7
Ninh Bình 7
Porto Alegre 7
Taranto 7
Amsterdam 6
Assago 6
Aversa 6
Bari 6
Cosenza 6
Curitiba 6
Guayaquil 6
Johannesburg 6
Lyon 6
Maryland Heights 6
Miami 6
Phoenix 6
Queens 6
Redwood City 6
Salvador 6
St Louis 6
Caracas 5
Casalnuovo di Napoli 5
Charlotte 5
Dhaka 5
Guangzhou 5
Hanover 5
Lima 5
Pune 5
Rende 5
Shenzhen 5
Thái Bình 5
Turin 5
Ankara 4
Belo Horizonte 4
Biên Hòa 4
Cape Town 4
Catania 4
Dakar 4
Denver 4
Fortaleza 4
Lahore 4
Latina 4
Manchester 4
Monheim 4
Montevideo 4
Nuremberg 4
Totale 3.957
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 137
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 98
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 93
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 86
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 84
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 79
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 79
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 78
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 77
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 74
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
Citrus bergamia: Kinetics of Antimicrobial Activity on Clinical Isolates 70
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 68
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 67
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 67
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 66
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 66
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 66
31st International papillomavirus conference Cape Town, 28 Febbraio - 4 Marzo 2017. 63
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 62
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 61
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 61
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 61
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 60
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 59
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 59
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 58
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 57
An Ascaris lumbricoides infection diagnosed by colonoscopy: A case report and a brief literature review 56
Virological Mechanisms in the Coinfection between HIV and HCV 56
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 55
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 54
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 54
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes 54
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 54
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. 53
Outcome of hbv screening and vaccination in a migrant population in southern italy 53
Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study 53
The issue of climate change and the spread of tropical diseases in Europe and Italy: vector biology, disease transmission, genome-based monitoring and public health implications. 52
Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six-Year Active Surveillance Study on Patients Admitted to a Teaching Hospital 51
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 51
Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression 50
SOLUBLE CD14 SUBTYPE - A NEW BIOMARKER IN PREDICTING OUTCOME OF CRITICALLY ILL SEPTIC PATIENTS: AN OBSERVATIONAL PROSPECTIVE STUDY. 50
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4 50
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients 50
Chapter: Next-generation sequencing and microbiome evaluation: Molecular microbiology and its impact on human health 50
Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area 50
Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era 49
Changing and Evolution of Influenza Virus: Is It a Trivial Flu? 49
Molecular characterization of autochthonous Hepatitis E virus detected from a human acute infection in the Calabria Region, Southern Italy 48
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital 47
Aspetti clinici ed epidemiologici dell’infezione da genotipo 4 di HCV 47
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 46
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy 46
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 46
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 46
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 46
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 46
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 46
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 45
Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients 45
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 44
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. 44
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 44
Cat-Scratch Diseases (CSD) con coinvolgimento splenico multifocale in paziente immunocompetente: contributo della diagnosi molecolare 44
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 43
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 43
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model 43
Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients. 43
Next Generation Sequencing and Microbiome Evaluation: Molecular Microbiology and Its Impact on Human Health 43
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 42
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 42
Does the Human Gut Virome Contribute to Host Health or Disease? 42
Role of IgG and IgM and proinflammatory non-specific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 42
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 41
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 41
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy 41
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients 41
Data presentation HCV virology 41
Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing. 41
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. 40
Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy 40
Ultra-deep sequencing and bioinformatics approach to detect natural resistance-associated variants in DAA-naïve HCV positive patients 40
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 40
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy). 40
MOLECULAR CHARACTERIZATION AND CLUSTER ANALYSIS OF SARS-COV-2 VIRAL ISOLATES IN KAHRAMANMARAŞ CITY, TURKEY: THE DELTA VOC WAVE WITHIN ONE MONTH 39
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 39
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 39
Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective study. 39
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 39
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 39
Update on HPV epidemiology in Calabria Region, Southern Italy. 39
Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. 38
Prevalenza di HCV3 ed HCV4 nella nuova era degli antivirali ad azione diretta (DAA) 38
ROLE OF TREG, BREG AND OTHER CYTOKINE SETS IN HOST PROTECTION AND IMMUNOPATHOLOGY DURING HUMAN LEISHMANIASIS: ARE THEY POTENTIAL VALUABLE MARKERS IN CLINICAL SETTINGS AND VACCINE EVALUATION? 37
RICONOSCIMENTO MOLECOLARE DEL DASABUVIR, TEGOBUVIR E SETROBUVIR NEL DOMINIO PALM I DELLA POLIMERASI DEL VIRUS DELL’EPATITE C, IN PRESENZA DELLA MUTAZIONE NATURALE 316N 37
Presepsin: a possible sepsis marker for critically ill patients? 37
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies 36
Totale 5.309
Categoria #
all - tutte 61.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022266 0 1 0 70 5 2 24 59 26 22 53 4
2022/2023638 196 59 17 54 41 44 19 28 76 33 57 14
2023/2024454 74 63 20 30 26 86 13 24 15 20 37 46
2024/20251.460 197 57 36 61 131 158 43 45 165 16 220 331
2025/20263.403 206 384 273 424 358 164 510 193 445 305 101 40
2026/2027183 45 138 0 0 0 0 0 0 0 0 0 0
Totale 6.643